In situ vaccination caused by diverse irradiation-driven cell death programs

Theranostics. 2024 Jan 12;14(3):1147-1167. doi: 10.7150/thno.86004. eCollection 2024.

Abstract

Interest surrounding the effect of irradiation on immune activation has exponentially grown within the last decade. This includes work regarding mechanisms of the abscopal effect and the success achieved by combination of radiotherapy and immunotherapy. It is hypothesized that irradiation triggers the immune system to eliminate tumors by inducing tumor cells immunogenic cell death (ICD) in tumor cells. Activation of the ICD pathways can be exploited as an in situ vaccine. In this review, we provide fundamental knowledge of various forms of ICD caused by irradiation, describe the relationship between various cell death pathways and the immune activation effect driven by irradiation, and focus on the therapeutic value of exploiting these cell death programs in the context of irradiation. Furthermore, we summarize the immunomodulatory effect of different cell death programs on combinative radiotherapy and immunotherapy. In brief, differences in cell death programs significantly impact the irradiation-induced immune activation effect. Evaluating the transition between them will provide clues to develop new strategies for radiotherapy and its combination with immunotherapy.

Keywords: Cell death programs; immunotherapy; in situ vaccine; irradiation.

Publication types

  • Review

MeSH terms

  • Cell Death
  • Humans
  • Immune System
  • Immunotherapy
  • Neoplasms* / therapy
  • Vaccination